NCT01925274 2019-01-08A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal CancerPfizerPhase 2 Terminated19 enrolled 32 charts